摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-pyridin-4-yl-4,5-dihydro-1H-pyrimidin-6-one

中文名称
——
中文别名
——
英文名称
2-pyridin-4-yl-4,5-dihydro-1H-pyrimidin-6-one
英文别名
——
2-pyridin-4-yl-4,5-dihydro-1H-pyrimidin-6-one化学式
CAS
——
化学式
C9H9N3O
mdl
——
分子量
175.19
InChiKey
LWZBRDHTBAGDDK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

文献信息

  • [EN] PREPARATION AND USES OF PYRIMIDINONE DERIVATIVES<br/>[FR] PRÉPARATION ET UTILISATIONS DE DÉRIVÉS DE PYRIMIDINONE
    申请人:CANCER RESEARCH TECH LTD
    公开号:WO2018055402A1
    公开(公告)日:2018-03-29
    The present invention relates to compounds of formula (I), and salts and solvates thereof, that function as inhibitors of cell division cycle 7 (Cdc7) kinase enzyme activity: (Formula (I)) wherein X, R1, R2, and n are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which Cdc7 kinase activity is implicated.
    本发明涉及式(I)的化合物,以及其盐和溶剂合物,其作为细胞分裂周期7(Cdc7)激酶酶活性的抑制剂:(式(I))其中X,R1,R2和n如本文所定义。本发明还涉及制备这些化合物的方法,包括它们的药物组合物,以及它们在治疗增殖性疾病(如癌症)以及其他涉及Cdc7激酶活性的疾病或病况中的用途。
  • PREPARATION AND USES OF PYRIMIDINONE DERIVATIVES
    申请人:Cancer Research Technology Limited
    公开号:EP3515903B1
    公开(公告)日:2020-10-21
  • LIBRARIES OF COMPOUNDS HAVING DESIRED PROPERTIES AND METHODS FOR MAKING AND USING THEM
    申请人:BIOBLOCKS, INC.
    公开号:US20150269356A1
    公开(公告)日:2015-09-24
    In alternative embodiments the invention provides libraries of compounds, or drugs or drug candidates, manufactured and selected for having a desired property such as a biological or a chemical activity, and methods for making and using them. In one embodiment, the invention provides methods for identifying desirable compounds from very large compound sets using a compound fragment as the query. In alternative embodiments, the invention provides methods of making compounds, and libraries of compounds, using a “feasible reaction” growth scheme.
  • US9946847B2
    申请人:——
    公开号:US9946847B2
    公开(公告)日:2018-04-17
  • [EN] LIBRARIES OF COMPOUNDS HAVING DESIRED PROPERTIES AND METHODS FOR MAKING AND USING THEM<br/>[FR] BANQUES DE COMPOSÉS AYANT DES PROPRIÉTÉS SOUHAITÉES ET PROCÉDÉS DE FABRICATION ET D'UTILISATION ASSOCIÉS
    申请人:BIOBLOCKS INC
    公开号:WO2014047463A2
    公开(公告)日:2014-03-27
    In alternative embodiments the invention provides libraries of compounds, or drugs or drug candidates, manufactured and selected for having a desired property such as a biological or a chemical activity, and methods for making and using them. In one embodiment, the invention provides methods for identifying desirable compounds from very large compound sets using a compound fragment as the query. In alternative embodiments, the invention provides methods of making compounds, and libraries of compounds, using a "feasible reaction" growth scheme.
查看更多